A Study on the Policy Implication on the Management of Narcotics Distribution for Medical Use.
- Author:
Su Yeon YU
1
;
Hyunmin CHO
;
Hyeun Ah KANG
;
Sukyeong KIM
Author Information
1. Health Insurance Review and Assessment Service, Seoul 06653, South Korea.
- Publication Type:Original Article
- Keywords:
Narcotics;
Narcotic drugs;
Psychotropic drugs;
Distribution;
Management
- MeSH:
Delivery of Health Care;
Humans;
Information Services;
Insurance, Health;
Korea;
Narcotics*;
Prescriptions;
Psychotropic Drugs
- From:Korean Journal of Clinical Pharmacy
2015;25(4):280-285
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVES: To suggest direction for improving policies by understanding current management of narcotics or psychotropic drugs and analyzing their distributions and usage. METHOD: We conducted a comparison analysis between health insurance claims and the amount supplied to health care institutions for narcotics or psychotropic drugs through health insurance claims data and drug distribution supply data from 2010 to 2012 collected from Korea Pharmaceutical Information Service Center (KPIS). Furthermore, we carried out literature investigation and online search to comprehend the current management of narcotics drugs in Korea. RESULTS: The amount supplied to medical institutions for all drugs in 2012 was 19.4 trillion won, which increased from 19.5 trillion in 2011 by 0.54%. For narcotic drugs, the amount supplied was 318.4 billion won in 2011 and increased to 335.1 billion won by 5.3% in 2012, which exceeded the rate of increase for the amount supplied for all drugs. The proportion of amount claimed in the total amount supplied to medical institutions for all drugs was 60.5% in 2012, whereas the proportion of amount claimed for narcotic drugs was 55.6%, which showed that narcotic drugs were used relatively less within health insurance. Furthermore, management of the current domestic distribution supply data focuses on manufacturing and medical institution supply stages. CONCLUSION: Hereafter, the management of narcotics or psychotropic drugs needs to be improved by reinforcing active monitoring in optimal prescription and usage in patients by collecting and analyzing information on drug usage of patients.
